Protective Effect of Dexmedetomidine Against Delayed Bone Healing Caused by Morphine Via PI3K/Akt Mediated Nrf2 Antioxidant Defense System

Overview

Journal Front Pharmacol

Date 2024 Jun 12

PMID 38863982

Authors

Yani Lou

Linfang Zou

Zhenyu Shen

Jianwei Zheng

Yuanqu Lin

Zhe Zhang

Xuankuai Chen

Jun Pan

Xutong Zhang

Affiliations

Soon will be listed here.

Abstract

Background: As a class of analgesics, opioids are frequently used to treat both acute and chronic moderate to severe pain. Patients frequently receive opioid painkillers after orthopedic accidents or surgeries. Evidence suggests that opioid drug users have a 55.1% higher risk of fracture and poor bone repair than non-users of opioid drugs. The key pathogenic alterations in the incidence and progression of poor bone repair are over apoptosis and aging of osteoblasts due to the stress caused by oxidation. Dexmedetomidine (Dex) has been proven to protect against a variety of degenerative illnesses by reducing oxidative stress. However, nothing is known about how it affects bone repair.

Methods: PI3K/Akt/Nrf2 pathway was detected by immunofluorescence and Western blot. SOD, CAT, JC-1, dihydroethidium and mitosox were used in the Oxidative Stress. Micro-CT, H&E and Masson's staining, immunohistochemically were performed to evaluate the therapeutic effects of DEX on calvarial defects in the morphine-induced rat model.

Results: We found that morphine-induced an imbalance in the metabolism and catabolism of primary rat Osteoblasts. However, these conditions could be inhibited by DEX treatment. In the meantime, DEX induced the expression of Nrf2-regulated antioxidant enzymes such as NQO1, HO-1, GCLm, GCLc, and TrxR1. DEX-mediated Nrf2 activation is linked to the PI3K/Akt signaling system. Furthermore, it has been established that intravenous DEX enhanced the growth of bone healing in a model of a surgically produced rat cranial lesion.

Conclusion: This is the first description of the unique DEX mechanism acting as a Nrf2 activator against morphine-mediated oxidative harm, raising the possibility that the substance may be used to prevent bone defects.

Citing Articles

Modulation of oxidative stress/NMDA/nitric oxide pathway by topiramate attenuates morphine dependence in mice.

Hussain S, Bahadar H, Khan M, Qazi N, Wazir S, Ahmad H Heliyon. 2024; 10(23):e40584.

PMID: 39719994 PMC: 11667026. DOI: 10.1016/j.heliyon.2024.e40584.

The effects of dexmedetomidine on thiol/disulphide homeostasis in coronary artery bypass surgery: a randomized controlled trial.

Ozguner Y, Altinsoy S, Kulturoglu G, Unal D, Ergil J, Neselioglu S BMC Anesthesiol. 2024; 24(1):402.

PMID: 39511476 PMC: 11542366. DOI: 10.1186/s12871-024-02794-1.

References

Corder G, Castro D, Bruchas M, Scherrer G . Endogenous and Exogenous Opioids in Pain. Annu Rev Neurosci. 2018; 41:453-473. PMC: 6428583. DOI: 10.1146/annurev-neuro-080317-061522. View

Sun Y, Zhao H, Mu D, Zhang W, Cui J, Wu L . Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Cell Death Dis. 2019; 10(3):167. PMC: 6379430. DOI: 10.1038/s41419-019-1416-5. View

Zhao X, Yu H, Yang Y, Wu W, Chen T, Jia K . Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway. Redox Biol. 2018; 18:124-137. PMC: 6068203. DOI: 10.1016/j.redox.2018.07.002. View

Li W, Khor T, Xu C, Shen G, Jeong W, Yu S . Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem Pharmacol. 2008; 76(11):1485-9. PMC: 2610259. DOI: 10.1016/j.bcp.2008.07.017. View

Jonason J, OKeefe R . Isolation and culture of neonatal mouse calvarial osteoblasts. Methods Mol Biol. 2014; 1130:295-305. PMC: 11103242. DOI: 10.1007/978-1-62703-989-5_22. View

Wang Z, Wu J, Hu Z, Luo C, Wang P, Zhang Y . Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis. Oxid Med Cell Longev. 2020; 2020:5454210. PMC: 7648709. DOI: 10.1155/2020/5454210. View

Yu C, Xiao J . The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging. Oxid Med Cell Longev. 2021; 2021:6635460. PMC: 8106771. DOI: 10.1155/2021/6635460. View

Reymond S, Vujic T, Schvartz D, Sanchez J . Morphine-induced modulation of Nrf2-antioxidant response element signaling pathway in primary human brain microvascular endothelial cells. Sci Rep. 2022; 12(1):4588. PMC: 8931063. DOI: 10.1038/s41598-022-08712-0. View

Zhuang Y, Wang Y, He B, He X, Zhou X, Guo S . Molecular recognition of morphine and fentanyl by the human μ-opioid receptor. Cell. 2022; 185(23):4361-4375.e19. DOI: 10.1016/j.cell.2022.09.041. View

10.

Ross D, Siegel D . The diverse functionality of NQO1 and its roles in redox control. Redox Biol. 2021; 41:101950. PMC: 8027776. DOI: 10.1016/j.redox.2021.101950. View

11.

King T, Vardanyan A, Majuta L, Melemedjian O, Nagle R, Cress A . Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer. Pain. 2007; 132(1-2):154-68. PMC: 2704581. DOI: 10.1016/j.pain.2007.06.026. View

12.

Saunders K, Dunn K, Merrill J, Sullivan M, Weisner C, Brennan Braden J . Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med. 2010; 25(4):310-5. PMC: 2842546. DOI: 10.1007/s11606-009-1218-z. View

13.

Sverrisdottir E, Lund T, Olesen A, Drewes A, Christrup L, Kreilgaard M . A review of morphine and morphine-6-glucuronide's pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain. Eur J Pharm Sci. 2015; 74:45-62. DOI: 10.1016/j.ejps.2015.03.020. View

14.

Taghavi S, Shahsavari Z, Adjaminezhad-Fard F, Ghorbani M, Ghorbanhosseini S, Salimi V . Evaluating the expression pattern of the opioid receptor in pituitary neuroendocrine tumors (PitNET) and the role of morphine and naloxone in the regulation of pituitary cell line growth and apoptosis. Biomed Pharmacother. 2022; 157:114022. DOI: 10.1016/j.biopha.2022.114022. View

15.

Wang H, Wang Q, Cai G, Duan Z, Nugent Z, Huang J . Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop NRF2 in cancer therapeutic resistance. Acta Pharm Sin B. 2022; 12(4):1871-1884. PMC: 9279715. DOI: 10.1016/j.apsb.2021.10.015. View

16.

Tang C, Hu Y, Gao J, Jiang J, Shi S, Wang J . Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sci. 2020; 257:118004. DOI: 10.1016/j.lfs.2020.118004. View

17.

Shi J, Yu T, Song K, Du S, He S, Hu X . Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway. Redox Biol. 2021; 41:101954. PMC: 8027777. DOI: 10.1016/j.redox.2021.101954. View

18.

Zhang M, An C, Gao Y, Leak R, Chen J, Zhang F . Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog Neurobiol. 2012; 100:30-47. PMC: 3623606. DOI: 10.1016/j.pneurobio.2012.09.003. View

19.

Benggon M, Chen H, Applegate R, Martin R, Zhang J . Effect of dexmedetomidine on brain edema and neurological outcomes in surgical brain injury in rats. Anesth Analg. 2012; 115(1):154-9. PMC: 3382053. DOI: 10.1213/ANE.0b013e31824e2b86. View

20.

Wang X, Yu J, Sun Y, Wang H, Shan H, Wang S . Baicalin protects LPS-induced blood-brain barrier damage and activates Nrf2-mediated antioxidant stress pathway. Int Immunopharmacol. 2021; 96:107725. DOI: 10.1016/j.intimp.2021.107725. View